BlackRock
ZURA icon

BlackRock’s Zura Bio ZURA Stock Holding History

BlackRock’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.3M Buy
3,614,695
+3,157,336
+690% +$15M ﹤0.01% 3210
2026
Q1 		$2.72M Buy
457,359
+87,994
+24% +$532K ﹤0.01% 4039
2025
Q4 		$1.94M Buy
369,365
+3,691
+1% +$14.6K ﹤0.01% 4121
2025
Q3 		$1.58M Sell
365,674
-212,453
-37% -$382K ﹤0.01% 4166
2025
Q2 		$607K Sell
578,127
-2,143,625
-79% -$2.56M ﹤0.01% 4402
2025
Q1 		$3.51M Buy
2,721,752
+8,288
+0.3% +$13.1K ﹤0.01% 3780
2024
Q4 		$6.78M Buy
2,713,464
+341,494
+14% +$1.22M ﹤0.01% 3603
2024
Q3 		$9.63M Buy
2,371,970
+1,170,891
+97% +$4.37M ﹤0.01% 3429
2024
Q2 		$4.2M Buy
1,201,079
+106,462
+10% +$434K ﹤0.01% 3747
2024
Q1 		$2.81M Sell
1,094,617
-14,327
-1% -$50.8K ﹤0.01% 3877
2023
Q4 		$5.18M Buy
1,108,944
+529,448
+91% +$2.65M ﹤0.01% 3680
2023
Q3 		$3.82M Buy
579,496
+173,366
+43% +$1.16M ﹤0.01% 3768
2023
Q2 		$3.33M Buy
+406,130
New +$3.26M ﹤0.01% 3865

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

BlackRock's ZURA Position: Q2 2026 in Review

BlackRock increased its Zura Bio (ZURA) stake by 690% in Q2 2026, buying an estimated $15M and bringing the position to 3,614,695 shares worth $21.3M. The position accounts for ﹤0.01% of the portfolio, ranked #3210.

BlackRock first reported a position in ZURA in Q2 2023 and has held it in 13 quarters since. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • BlackRock held 3,614,695 shares of Zura Bio worth $21.3M as of Q2 2026.
  • BlackRock bought 3,157,336 Zura Bio shares in Q2 2026, an estimated $15M.
  • Zura Bio made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3210 holding.
  • BlackRock first reported a position in Zura Bio in Q2 2023 and has held it in 13 quarters since.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.